These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1363080)

  • 1. Ocular side effects of selected systemic drugs.
    Jaanus SD
    Optom Clin; 1992; 2(4):73-96. PubMed ID: 1363080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs affecting the eye.
    Taylor F
    Aust Fam Physician; 1985 Aug; 14(8):744-5. PubMed ID: 2864912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular toxicity of systemic medications: a case series.
    To TQ; Townsend JC
    Optometry; 2000 Jan; 71(1):29-39. PubMed ID: 10680416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of the drugs most frequently administered to the elderly--Part II.
    Lyle WM; Hayhoe DA
    J Am Optom Assoc; 1976 Sep; 47(9):1132-40. PubMed ID: 14987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced ocular disorders.
    Li J; Tripathi RC; Tripathi BJ
    Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy and the lack of oculo-visual complaints from those with mental illness and dual diagnosis.
    Donati RJ; Maino DM; Bartell H; Kieffer M
    Optometry; 2009 May; 80(5):249-54. PubMed ID: 19410230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular toxicity of systemic drugs. A review of the effects of seven commonly used agents.
    Davidorf FH
    Ohio State Med J; 1972 Nov; 68(11):1022-6. PubMed ID: 5079160
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual changes secondary to initiation of amiodarone: a case report and review involving ocular management in cardiac polypharmacy.
    Castells DD; Teitelbaum BA; Tresley DJ
    Optometry; 2002 Feb; 73(2):113-21. PubMed ID: 12365708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toxic lesions of the organ of vision caused by chloroquine derivatives].
    Kolotova AI; Ermakov NV
    Vestn Oftalmol; 2003; 119(1):39-42. PubMed ID: 12608045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Harmful effects of common drugs on the visual apparatus. Diuretics].
    Watillon M; Robe-Vanwyck A
    Bull Soc Belge Ophtalmol; 1972; 160(1):215-37. PubMed ID: 5047212
    [No Abstract]   [Full Text] [Related]  

  • 11. Miotic drugs: a review of ocular, visual, and systemic complications.
    Rengstorff R; Royston M
    Am J Optom Physiol Opt; 1976 Feb; 53(2):70-80. PubMed ID: 1084694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular toxicity of systemic drugs.
    Sammartino JP; Soll DB
    Am Fam Physician; 1985 Jan; 31(1):226-9. PubMed ID: 3966311
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinically important ocular reactions to systemic drug therapy.
    Rennie IG
    Drug Saf; 1993 Sep; 9(3):196-211. PubMed ID: 8240725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Harmful effects of common drugs on the visual apparatus. Minor analgesics, antipyretics, nonsteroid anti-inflammatory and antirheumatic drugs].
    Watillon M; Robe-Vanwijck A
    Bull Soc Belge Ophtalmol; 1972; 160(1):118-69. PubMed ID: 4537985
    [No Abstract]   [Full Text] [Related]  

  • 15. Optometric implications of systemic drug therapy.
    Canon SH
    J Am Optom Assoc; 1985 Nov; 56(11):843-4. PubMed ID: 4078206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rheumatoid arthritis: unknown long-term effects.
    Prescrire Int; 2001 Apr; 10(52):55-61. PubMed ID: 11718162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary disease due to antirheumatic agents.
    Zitnik RJ; Cooper JA
    Clin Chest Med; 1990 Mar; 11(1):139-50. PubMed ID: 1969788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular complications of neurological therapy.
    Hadjikoutis S; Morgan JE; Wild JM; Smith PE
    Eur J Neurol; 2005 Jul; 12(7):499-507. PubMed ID: 15958088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced visual disturbance].
    Imaizumi M; Ikebe T; Ikewaki J; Nakatsuka K
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():386-9. PubMed ID: 18074568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.